Purchases and Sales Made in Q4 2023 in Theseus Pharmaceuticals, Inc. (THRX)
This table provides information about the institutional ownership of Theseus Pharmaceuticals, Inc. (THRX) during Q4 2023. The information is specifically focused on institutions that hold shares of Theseus Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-1.14K- 16.89% |
$2.42K - $4.77K
|
5.62K
$0
|
|
|
Feb 07, 2024
Q4 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-2.01K- 4.35% |
$4.26K - $8.39K
|
44.1K
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-2.75K- 1.74% |
$5.82K - $11.5K
|
155K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-8.54K- 37.7% |
$18.1K - $35.7K
|
14.1K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-10.4K- 32.65% |
$22.1K - $43.7K
|
21.6K
$0
|
|
|
Jan 19, 2024
Q4 2023
|
Denali Advisors LLC
|
SELL
|
- |
-24.1K- 18.84% |
$51.1K - $101K
|
104K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-48.7K- 27.1% |
$103K - $203K
|
131K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-130K- 5.79% |
$276K - $544K
|
2.12M
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-163K- 62.92% |
$346K - $682K
|
96.2K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-169K- 93.1% |
$358K - $706K
|
12.5K
$0
|